Deborah loved geeky science and she would have been so proud of Bowelbabe lab, say family as unit is named in her honour
Last week the Stem Cell and Cancer Biology Lab at the Francis Crick Institute, near King's Cross station in London, was officially renamed The Bowelbabe Laboratory in her honour.
8
8
Her brother Ben and sister Sarah Wieczorek took part in Sunday's London Marathon, both dressed as a poo, to raise money for the Bowelbabe Fund.
Ben, 34, told The Sun: 'Debs loved geeky science, especially this project where they are growing organoids and mini bowels.
'Whether it's cutting-edge research into personalised medicine or early detection, she loved it and she wanted to set up this fund to do exactly this.'
And Debs' husband, Seb Bowen told how she would have been 'unbelievably proud' to see the impact her Fund is having.
'Exciting but bittersweet'
He said: 'I felt so many emotions, but the overwhelming one was a sense of enormous pride at Deborah's fund being a part of this amazing, world-class institution.'
Sun columnist Dame Debs died from bowel cancer aged just 40 in 2022 but not before starting a massive charity and awareness movement to help save others from suffering the same fate.
Cash from her £17million legacy Bowelbabe Fund is now paying scientists on the frontline of bowel cancer research.
They are growing tiny organs in petri dishes and conducting DNA analysis to work out how to catch and treat the devastating disease.
The Sun joined Debs' family last week for a tour of the facility with researchers, Cancer Research UK and the Health Secretary Wes Streeting.
Ben added: 'We've all enjoyed learning the science side of things. Like many families, you get into it when you are impacted by it.
Sun Health Explainer: Bowel Cancer
'Debs was fortunate enough to be with us for five years plus because of some of this research, and during that time she brought us into the loop and kept beating the drum for better awareness and understanding.
'It is always bittersweet but it's really exciting for the family to see that the money generously donated by the public is going to great use.'
Bowel cancer is one of the most common types of tumour in the UK and the second biggest cancer killer.
Around 17,000 Brits die from the disease each year, fewer only than lung cancer which claims 35,000 lives.
Half of cases could be prevented with healthier living but many are harder to explain.
Scientists are particularly worried that the disease is becoming more common in young adults such as Debs, who was diagnosed aged just 35.
Michelle Mitchell, chief executive of Cancer Research UK, said: 'Bowel cancer research is a significant priority for us. We are seeing a dramatic in- crease in early onset cancer around the world. We don't exactly know why yet, but that's why more research is absolutely critical.'
Dr Ian Walker, director of policy at the charity, added: 'The key thing for us is that we know if you detect bowel cancers early you have a significant change in your prognosis.
'Patients detected with very early stage bowel cancer have 90-plus per cent survival after five years.
'Whereas if you detect bowel cancer in the later stage of stage four that can be around only ten per cent.'
Scientists working in the Bowelbabe lab, led by Dr Vivian Li, are studying early warning proteins in at-risk patients.
They hope to be able to detect chemical signals in blood or poo samples that could help with faster diagnosis of less common tumours.
Analysing genes that appear only in people with cancer could also help to develop early warning signs and provide targets for treatment.
A big focus for the team is the issue of chemotherapy resistance.
This occurs when treatment stops working because a tumour gets used to the drugs being used to attack it.
8
8
Dr Li estimates this happens eventually in 90 per cent of patients with stage four cancer that has spread.
She told The Sun: 'One of our recent findings is a gene called SOX2, which potentially contributes to chemotherapy resistance.
'That gene drives the cancer cell to go to sleep and the chemotherapy does not work on sleeping cells — it can only kill the cancer when the cells are dividing. Then when you withdraw the drug the cells can grow again.
'Now we're trying to revert that to sensitise the patient to chemotherapy.'
Dr Li's lab is also trying new approaches to immunotherapy, which harnesses the body's own immune system to attack cancer cells.
They are able to test new treatment methods or genetic therapies on fascinating organoids in the lab.
Organoids are tiny human organs or tumours grown in petri dishes using cells harvested from patients.
They react just like the cells in the body parts doctors want to target, meaning researchers can test how different approaches might work in the clinic.
'Pushing the frontiers'
Supporting Dr Li's project was a no-brainer for Debs' family.
Towards the end of her life, Dame Debs had an organoid of her own bowel tumour created, at the Institute of Cancer Research in London.
She was also a regular visitor to laboratories including those at The Crick where she helped lift the curtain on the cutting-edge science giving so many cancer patients hope.
After being diagnosed in 2016, the former deputy head teacher made it her mission to raise awareness, dressing up in poo emojis to break taboos and urging people: 'Check your poo!'
FUND HIT £17M
THE BowelBabe Fund was set up in May 2022 after Debs revealed in her final Sun column she had returned to her parents' home to receive palliative care.
Dame Deborah made a final plea for people to help her hit £10million and, since her death, the fund soared to £17million.
The cash has funded projects – including a new X-ray machine at the Royal Marsden Hospital in Surrey, where she was treated, and a bowel cancer roadshow to raise awareness.
Most of the money is funding cutting edge cancer research, including new treatments, better testing, using AI for diagnosis and understanding how tumours spread.
If you would like to donate go to bowelbabe.org
She shared the signs and symptoms every one should know in her Sun column, Things Cancer Made Me Say, and called for action to invest in research to find new treatments.
Deborah often said she was 'riding on the wings of science' — a reference to the fact new, cutting-edge treatments helped her survive for five-and-a-half years, when statistics suggested she might not live a year.
So seeing her name adorned on the door of a lab at The Crick was such a special moment for her family.
Her parents Heather and Alistair, told The Sun: 'Deborah would be over the moon to know that a lab dedicated to finding new treatments bears her name.'
8
Seb added: 'With talented scientists from around the world and CRUK, the UK is at the forefront of cancer research, and I'm not sure many people realise that.
'Deborah would've shared my pride, she would've found it all really, really exciting.
'To see money raised in her name helping fund projects that will hopefully one day help save lives, was exactly what she hoped for.
'It's inspiring to know the fund has the potential to have such a positive impact.'
One of the reasons Dame Deborah's legacy is so impactful is that every time she's in The Sun or in the media, we see searches for bowel cancer symptoms going up and people going and getting tested
Wes Streeting
Her parents added: 'Deborah didn't want us all sitting around feeling sad, and in setting up the Bowelbabe Fund she ensured that we always have a really positive focus.
'She has, and continues to be, at the forefront of our minds when we decide on the projects to support — made easier by the fact we all know what she would've wanted. To know that she is still helping to save lives almost three years on, makes us all very proud.'
Wes Streeting, a cancer survivor himself, visited the lab last week with Debs' family.
He said: 'One of the reasons Dame Deborah's legacy is so impactful is that every time she's in The Sun or in the media, we see searches for bowel cancer symptoms going up and people going and getting tested.
'The work that is now being done in her name and the fundraising that has taken place in her name — thanks to her amazing family — is pushing the frontiers of medical science in this area.
'That legacy lives on so it's entirely fitting that we've now got the Bowelbabe Lab here with Cancer Research UK at the Crick Institute.'
8
8
8
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
21 minutes ago
- Glasgow Times
Speed of improvement in cancer survival rates ‘slowing', say experts
The news comes as a study suggests survival between the most and least deadly types of the disease is wider than ever before. A national cancer plan was 'essential' to 'bring cancer survival trends back towards the best in the world', researchers said. The study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales from 1971 to 2018. Using records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, experts estimated net survival for up to 10 years after diagnosis for around 10.8 million people. They found that in 2018, the CSI for all cancers combined a decade after diagnosis was 49.8%, higher than the CSI at one year for those diagnosed in 1971/72. Researchers hailed the figure as 'remarkable', but warned that the 'speed of improvement in survival has slowed down'. In the five years from 2000/01 to 2005/06, the 10-year CSI rose by 4%, from 41.2% to 45.2%. But between 2010/11 and 2015/16, the rise was 1.4%, from 47.9% to 49.3%. There were also major gaps in survival when it came to different cancer types. For example, 10-year survival for testicular cancer was 97%, compared with 4.3% for pancreatic cancer. Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK. But survival for other types, such as stomach, lung and brain cancer, had increased by only a small amount in the past 50 years. Writing in the Lancet Regional Health – Europe, researchers warned this slowdown for individual cancers implied a 'system-wide challenge'. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past. 'But the reality is that this progress is slowing – and for some cancers, it never got going in the first place.' The Government launched a call for evidence to help shape a national cancer plan in February. The blueprint aims to outline actions to transform how the disease is treated in a bid to reduce deaths. Ms Mitchell said: 'The upcoming National Cancer Plan for England must include commitments to spot more cancers earlier, as well as backing research into new treatments so that each patient, regardless of their diagnosis, can hope for more moments with the people they love.' Michel Coleman, a professor of epidemiology and statistics at LSHTM, said: 'Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer. 'Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences. 'This study was only possible because of data on millions of patients from cancer registries in England and Wales. 'It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control. 'The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it.' Cancer Research UK is calling for the national cancer plan to slash waiting times for diagnosis and treatment, saying some patients face unacceptable delays. The plan should also improve early diagnosis of cancer, with plans to boost participation in existing screening programmes and a commitment to rolling out lung cancer screening fully in England by 2029. A Department of Health and Social Care spokesperson said: 'We are prioritising cancer care as we turn around more than a decade of neglect of our NHS. 'We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year. 'The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types.'
Scottish Sun
8 hours ago
- Scottish Sun
Terrifying link between booze and deadliest cancer discovered – are you drinking too much?
Some 10,500 people are diagnosed with the disease in the UK each year, with more than half dying within three months of diagnosis ACCELERATOR Terrifying link between booze and deadliest cancer discovered – are you drinking too much? Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SCIENTISTS may have discovered how booze can trigger pancreatic cancer - the deadliest cancer in the world. They think alcohol causes inflammation in the pancreas, damaging cells and leading to precancerous lesions, which can, over time, turn into deadly tumors. Sign up for Scottish Sun newsletter Sign up 2 Alcohol could be speeding up the deadly development of pancreatic cancer Credit: Getty 2 Scientists uncover how booze transforms healthy pancreas cells into cancerous ones Credit: Getty Some 10,500 people are diagnosed with the disease in the UK each year, according to Cancer Research UK. And only about only around one in 20 survive the disease for 10 years or more. More than half of people die within three months of diagnosis. This is partly because it shows no symptoms until it has already spread to other parts of the body, making it incredibly hard to treat. While surgery, chemotherapy and radiation can help extend life, they rarely offer a cure. Previous research, cited by Cancer Research, has already established a link between alcohol and pancreatic cancer. It shows that the risk is higher for people who consume three or more units of alcohol a day, compared to those who drink less. To put it in perspective, three units is roughly the equivalent of one pint (568ml) of 5.2 per cent lager or one large glass (250ml) of 12 per cent wine. The fresh study, published in Cellular and Molecular Gastroenterology and Hepatology, sheds new light on how alcohol-induced inflammation accelerates the development of the deadly disease. The researchers, from the University of Miami Miller School of Medicine, found that alcohol activates a molecule called CREB (cAMP response element binding protein) in the pancreas. Understand the signs and symptoms of pancreatic cancer to beat it early This molecule plays a key role in how alcohol-induced inflammation leads to cancer. 'CREB is not just a mediator of inflammation; it is a molecular orchestrator that permanently converts acinar cells into precancerous cells, which ultimately progress to high-grade neoplasia,' said Dr Nagaraj Nagathihalli, senior author of the study. This means that CREB turns healthy pancreatic cells into cells that are more likely to become cancerous. Once this process starts, it can't be undone, significantly increasing the risk of developing pancreatic cancer. Dr Siddharth Mehra, the study's lead author, added, 'Our model serves as an important platform for understanding how chronic inflammation related to alcohol consumption accelerates the development of pancreatic cancer.' The study suggests that blocking CREB could potentially stop the cancerous process in those who continue to booze. 'By targeting CREB, we may be able to prevent the development of pancreatic tumors, even in those who continue to drink,' Dr Mehra added. NHS to search for pancreatic cancer cases In June, the NHS launched a drive to catch pancreatic cancer before symptoms show. GP teams will comb through patient records to identify anyone over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss. Figures suggest that around half of people diagnosed with pancreatic cancer have been diagnosed with type 1 or 2 diabetes recently. The doctors will contact patients and offer them urgent blood tests and CT scans to either diagnose the cancer or rule it out. Newly diagnosed diabetes patients often have similar symptoms to a person with early-stage pancreatic cancer because the cancer destroys the same insulin-producing cells that are also affected by diabetes. More than 300 GP practices in England will be involved in the three-year pilot, which is set to be fully operational by this autumn.
Scottish Sun
9 hours ago
- Scottish Sun
Millions of Brits ‘can't remember the last time they drank glass of water' – with many using tea for hydration
DRINK UP Millions of Brits 'can't remember the last time they drank glass of water' – with many using tea for hydration Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A POLL of 2,000 adults revealed 40 per cent rely primarily on cups of tea to stay hydrated, with 30 per cent opting for coffee and 17 per cent fizzy drinks. With Boomers twice as likely as Gen Z to turn to tea for their hydration needs (56 per cent vs 23 per cent). Sign up for Scottish Sun newsletter Sign up And women are more likely than men to fail to drink enough water, with 36 per cent of females reporting this compared to 27 per cent of men. Just 17 per cent are drinking enough water, according to NHS guidelines which recommend up to eight glasses a day, according to the research commissioned by hydration drink Más+ by Messi, which is promoting positive hydration to keep Brits on top of their game. Nearly a tenth of all adults polled (nine per cent) don't like the taste of plain water, while 43 per cent claimed it tastes boring. It also emerged 10 per cent of the parents polled don't think their children drink enough each day. While the study, which also polled 837 teenagers, found 15 per cent of them drink plain water only a few times a week at most. In fact, one mum, Kelly Mulligan, 53, says her son, Max, nine, hasn't sunk a glass of plain water since he was four years old. Despite Max having regular thirst cues, he's "never liked the taste" of water because "there's no flavour.' Instead, the youngster would rather drink apple juice, which Kelly dilutes with water to keep Max's sugar content down. Kelly, from Brighton, who runs her own cleaning business, said: 'Max has never liked plain water - he says there's no flavour. 'I agree – I don't drink plain water either. I can only drink carbonated water or tea. 'Max will take little sips of water if he needs to, but he's always thirsty and says plain water doesn't quench his thirst. 'He loves fresh apple juice, but to make sure he's not having too much natural sugar, I water it down. 'He's fine with that, and it helps me to know that he is having some form of water. Mum of one, Kelly added: 'Max has to take a bottle of water to school because they don't allow anything [else], but how much he actually drinks of that, I'm not sure. 'He's healthy and happy, so I have no concerns. He has a varied diet and keeps active. It isn't like he's drinking no liquids at all. 'The diluted apple juice is a middle ground which helps keep my concerns for his teeth a bay.' The study also found of the 13–17-year-olds polled, 34 per cent prefer other drinks to water, while 26 per cent 'forget' to drink it. While 29 per cent of adults believed tea, coffee and soft drinks are as effective as water when it comes to hydration. Just 12 per cent actively monitor their water intake, with 60 per cent not bothering at all – and the remainder trying to keep mental notes on how much they've had. But 17 per cent often experience symptoms they believe are due to dehydration, such as headaches or fatigue. The issues are often passed down to children, as 54 per cent of the parents polled struggle to get kids to drink plain water on a regular basis. This leaves 41 per cent feeling worried, with three quarters having to 'force' their children to stay hydrated. Sophie Van Ettinger, global VP Más+ by Messi, said: 'It's alarming the number of people who are not aware they are dehydrated daily and will often go through days experiencing a lack of energy or headaches, not realising a simple glass of water or even a hydration drink is the solution.' Leo Messi, co-founder for the drink, added: 'As an athlete, I know the importance of hydration for peak performance.'
